Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study

[1]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[2]  D. Francis,et al.  Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations , 2013, International journal of cardiology.

[3]  A. Stewart,et al.  Genes and coronary artery disease: where are we? , 2012, Journal of the American College of Cardiology.

[4]  Andrew Steptoe,et al.  Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data , 2012, The Lancet.

[5]  S. Blair,et al.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy , 2012, BDJ.

[6]  D. Gu,et al.  Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis , 2012, BMC Medical Genetics.

[7]  J. Heinrich,et al.  FADS1 FADS2 Gene Cluster, PUFA Intake and Blood Lipids in Children: Results from the GINIplus and LISAplus Studies , 2012, PLoS ONE.

[8]  A. Esteghamati,et al.  Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes , 2012, Molecular Biology Reports.

[9]  Yan Li,et al.  Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: A meta-analysis , 2012, Molecular and Cellular Endocrinology.

[10]  J. Manson,et al.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. , 2011, Atherosclerosis.

[11]  A. Ben Abdelaziz,et al.  Single-nucleotide polymorphisms at the adiponectin locus and risk of coronary artery disease in Tunisian coronaries , 2011, Journal of cardiovascular medicine.

[12]  N. Al-Daghri,et al.  Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes , 2011, Molecular Biology Reports.

[13]  E. Lambert,et al.  The -308 G/A polymorphism of the tumour necrosis factor-α gene modifies the association between saturated fat intake and serum total cholesterol levels in white South African women , 2011, Genes & Nutrition.

[14]  J. Tuomilehto,et al.  Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study , 2011, BMC Medical Genetics.

[15]  J. Behravan,et al.  Association between 45T/G Polymorphism of Adiponectin Gene and Coronary Artery Disease in an Iranian Population , 2011, TheScientificWorldJournal.

[16]  J. Pankow,et al.  Variants in the Adiponectin Gene and Serum Adiponectin: The Coronary Artery Development in Young Adults (CARDIA) Study , 2010, Obesity.

[17]  L. Peltonen,et al.  A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses , 2010, The Lancet.

[18]  C. Zhong,et al.  A lack of association between adiponectin polymorphisms and coronary artery disease in a Chinese population , 2010, Genetics and molecular biology.

[19]  C. Specchia,et al.  Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population , 2010, Therapeutic advances in cardiovascular disease.

[20]  Martin O'Flaherty,et al.  Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. , 2010, JAMA.

[21]  S. Yusuf,et al.  Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[22]  H. Yoshida,et al.  Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. , 2009, Atherosclerosis.

[23]  L. Chuang,et al.  Interaction of ADIPOQ genetic polymorphism with blood pressure and plasma cholesterol level on the risk of coronary artery disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[24]  M. Inoue,et al.  Perceived Level of Life Enjoyment and Risks of Cardiovascular Disease Incidence and Mortality: The Japan Public Health Center–Based Study , 2009, Circulation.

[25]  C. Fox,et al.  Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits , 2008, Diabetes.

[26]  X. Zhang,et al.  Coronary heart disease in China , 2008, Heart.

[27]  T. Spector,et al.  Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity , 2008, Journal of Human Genetics.

[28]  Olle Melander,et al.  Polymorphisms associated with cholesterol and risk of cardiovascular events. , 2008, The New England journal of medicine.

[29]  T. Funahashi,et al.  Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[30]  R. Luben,et al.  Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. , 2007, European heart journal.

[31]  R. McPherson,et al.  Identifying genes for coronary artery disease: An idea whose time has come. , 2007, The Canadian journal of cardiology.

[32]  J. Manson,et al.  Single Nucleotide Polymorphisms at the Adiponectin Locus and Risk of Coronary Heart Disease in Men and Women , 2007, Obesity.

[33]  S. Humphries,et al.  Common Adiponectin Gene Variants Show Different Effects on Risk of Cardiovascular Disease and Type 2 Diabetes in European Subjects , 2007, Annals of human genetics.

[34]  O. Baysan,et al.  Evaluation of plasma adiponectin levels in young men with coronary artery disease , 2007, Acta cardiologica.

[35]  T. Pearson,et al.  Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. , 2007, Translational research : the journal of laboratory and clinical medicine.

[36]  A. Doria,et al.  Genetic Influences of Adiponectin on Insulin Resistance, Type 2 Diabetes, and Cardiovascular Disease , 2007, Diabetes.

[37]  K. Schenck-Gustafsson,et al.  Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study , 2007, Journal of internal medicine.

[38]  L. Lai,et al.  ATP-Binding Cassette Transporter A1 Gene I823M Polymorphism Affects Plasma High-Density Lipoprotein Cholesterol Level and Modifies the Effect of Low High-Density Lipoprotein Cholesterol on the Risk of Coronary Artery Disease , 2007, Cardiology.

[39]  P. Nilsson,et al.  Plasma Adiponectin Levels in Relation to Carotid Intima Media Thickness and Markers of Insulin Resistance , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[40]  S. Cummings,et al.  Serum adiponectin and coronary heart disease risk in older Black and White Americans. , 2006, The Journal of clinical endocrinology and metabolism.

[41]  E. Barrett-Connor,et al.  Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. , 2006, American journal of epidemiology.

[42]  D. Balding.  A tutorial on statistical methods for population association studies , 2006, Nature Reviews Genetics.

[43]  K. Sung,et al.  Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. , 2006, Endocrine journal.

[44]  J. Danesh,et al.  Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.

[45]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[46]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[47]  J. Manson,et al.  Adiponectin Genetic Variability, Plasma Adiponectin, and Cardiovascular Risk in Patients With Type 2 Diabetes , 2006, Diabetes.

[48]  L. Køber,et al.  Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.

[49]  B. Paulweber,et al.  Plasma Adiponectin Levels and Sonographic Phenotypes of Subclinical Carotid Artery Atherosclerosis: Data From the SAPHIR Study , 2005, Stroke.

[50]  H. Brenner,et al.  Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. , 2005, European heart journal.

[51]  P. Libby,et al.  Pathophysiology of Coronary Artery Disease , 2005, Circulation.

[52]  M. Arca,et al.  The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years) , 2005, Journal of Molecular Medicine.

[53]  E. Rimm,et al.  The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. , 2005, Diabetes.

[54]  David M Maahs,et al.  Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification , 2005, Circulation.

[55]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[56]  A. Doria,et al.  The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. , 2004, Diabetes care.

[57]  C. Dina,et al.  The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non‐insulin‐dependent) diabetes mellitus , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[58]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[59]  Sidney C. Smith,et al.  Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. , 2004, Circulation.

[60]  T. Ogihara,et al.  Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[61]  K. Drummond,et al.  Nutrition for Foodservice and Culinary Professionals , 2003 .

[62]  P. Froguel,et al.  Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.

[63]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[64]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[65]  M. Matsuda,et al.  Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.

[66]  M. Matsuda,et al.  Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.

[67]  L. Iacoviello,et al.  [Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[68]  S. Kihara,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[69]  NoriyukiOuchi,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[70]  J. Strong,et al.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[71]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[72]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[73]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[74]  E. Boerwinkle,et al.  Gene-Environment Interactions and Gene Therapy in Atherosclerosis , 1994 .

[75]  R. Magno,et al.  Coronary heart disease , 1957 .

[76]  B. Han,et al.  Interactions between ADIPOQ gene variants and dietary monounsaturated: saturated fatty acid ratio on serum lipid levels in Korean children. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[77]  Danielle A. Jones,et al.  Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk 'Golden Years' type 1 diabetes cohort. , 2011, Diabetes research and clinical practice.

[78]  M. González-Gay,et al.  Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. , 2011, Tissue antigens.

[79]  C. Bauters,et al.  [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.

[80]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[81]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[82]  T. Cheng.  Coronary heart disease in China. , 1999, Hospital medicine.

[83]  F. Sebening,et al.  [Coronary artery disease]. , 1980, Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung.